Our 2023 Portland show features interactive off-site event at ChemHistory, Oregon’s premier compliance laboratory, in an immersive full day experience prior to conference.
Cannabis Science Conference (“CSC”), the premier cannabis science conference event focusing on analytical science, medical cannabis, cultivation, and psychedelics, announced today their pre-conference off-site workshop, Canna Boot Camp, taking place April 19 at ChemHistory, a quality control testing laboratory located in Milwaukie, Oregon.
Canna Boot Camp is CSC’s full-day off-site workshop covering a wide range of cannabis science topics including cultivation, pre-processing, sample prep, analytical testing, extraction, and manufacturing. CSC brings together industry experts to educate attendees in an interactive, workshop setting, located off-site from the conference the day before the show. Canna Boot Camp attendees will rotate through interactive educational zones at ChemHistory, and gain a full understanding of how the cannabis industry works from seed to sale. ChemHistory is Oregon’s premier laboratory providing comprehensive quality control/quality assurance (QA/QC), ensuring safety and regulatory compliance.
"CSC's mission is to promote knowledge and empowerment through education, and Canna Boot Camp provides an exciting interactive opportunity for attendees to learn in an immersive, real-life location," said Megan L'Heureux, spokesperson for CSC. "We’re excited to be working with Alex Hoggan and his team at ChemHistory to bring together experts and enthusiasts to share their knowledge and perspectives. Canna Boot Camp is always well-attended by those seeking a greater understanding of cannabis science, for all skill levels. Our agenda will include in-depth discussions on topics such as analytical testing, cultivation, medical cannabis, processing, and more."
The Cannabis Science Conference show floor event, from April 20-21, will feature several key medical sessions, including "Low and Ultra-Low Doses of Cannabinoids: Are We Missing the Sweet Spot?" by Dr. Dustin Sulak, DO, and "MDMA/Psychedelic-Assisted Therapy: The Path to Potential FDA Approval" by Dr. Sue Sisley, MD. There will also be a panel discussion on quality assurance and safety in cannabis, psilocybin, and hemp, as well as a panel discussion on the results from the first NIH-funded population-based study of medical marijuana.
CSC will be hosting four main tracks, including Analytical Science, Medical Cannabis, Cultivation, and Psychedelics. The conference will also feature a special focus on cannabis and veterans, with a special screening of the movie Unprescribed, which explores how veterans are turning to cannabis as a safer alternative to pharmaceuticals. Amid the opioid and suicide epidemics, increasing numbers of veterans are turning to cannabis and psychedelics, and CSC will be hosting a discussion with filmmaker Steve Ellmore on the efficacy of cannabis as a treatment alternative. The Unprescribed movie reveals a history of prohibition steeped in racism and political motivation.
Cannabis Science Conference will have veterans available to speak with at the conference, including Medical Track Program Chair Cherissa Jackson, RN, who served 23 years of active-duty military service with 10 years as a US Air Force Nurse.
See more details about Canna Boot Camp here.
Learn more about the movie Unprescribed here.
For the full show agenda, please visit the CSC website.
To apply for a media pass, including access to Canna Boot Camp, please contact CSCEvents@cmwmedia.com.
CSC previously ran their cannabis scientific event in Portland in 2019, and has plans to offer shows in other emerging markets around the country in coming months, with plans to run two shows per year in regions where conversations are taking place. Stay tuned for information on other upcoming events.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.